The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis

Lixiang Le1, Haojie Shan2, Yiwei Lin2

  • 1Department of Orthopedic Surgery, the Second Affiliated Hospital of Soochow University, China.

Insights

Pellino E3 Ubiquitin Protein Ligase Family Member 3 (Peli3) deficiency exacerbates osteomyelitis by increasing inflammation. Peli3 degrades Receptor-interacting serine/threonine-protein kinase 2 (RIPK2), suggesting RIPK2 as a therapeutic target for bone infection.

Area of Science:

  • Immunology
  • Molecular Biology
  • Orthopedics

Background:

  • Osteomyelitis, a severe bone infection, lacks a universal treatment protocol.
  • Receptor-interacting serine/threonine-protein kinase 2 (RIPK2) is implicated in osteomyelitis, but its mechanism is unclear.
  • Pellino E3 Ubiquitin Protein Ligase Family Member 3 (Peli3) role in osteomyelitis is not well-defined.

Purpose of the Study:

  • To elucidate the role of Peli3 in osteomyelitis pathogenesis.
  • To investigate the interaction between Peli3 and RIPK2 in the context of bone infection.
  • To explore potential therapeutic targets for osteomyelitis.

Main Methods:

  • Induction of osteomyelitis in wild-type and Peli3-deficient mice using Staphylococcus aureus.
  • Stimulation of RAW264.7 cells and bone marrow-derived macrophages with lipopolysaccharide (LPS).
  • Assessment of inflammatory cytokine expression and osteomyelitis severity.
  • Analysis of Peli3-mediated degradation of RIPK2 via ubiquitination.

Main Results:

  • Peli3 knockdown in macrophages increased inflammatory cytokine expression (IL-1β, IL-6, TNF-α) upon LPS stimulation.
  • Peli3-deficient mice exhibited heightened inflammation and more severe osteomyelitis symptoms after S. aureus infection.
  • Peli3 was found to target and degrade RIPK2 through K48-linked ubiquitination.
  • Peli3 negatively modulates osteomyelitis by degrading RIPK2.

Conclusions:

  • Peli3 plays a protective role in osteomyelitis by degrading RIPK2.
  • RIPK2 signaling contributes to osteomyelitis severity.
  • Targeting RIPK2 may offer a novel therapeutic strategy for treating osteomyelitis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.8K